The Neurocritical Care Society's Curing Coma Campaign is excited to release Common Data Elements for studies of Disorders of Consciousness.
Paper Collection: https://t.co/sGhiAKNUnt
Case Report Forms: https://t.co/iraVbL7zTz
#NCS2024@neurocritical@CuringComa@NIH_NINDS
Suarez et al: Common Data Elements for Disorders of Consciousness: Recommendations from the Working Group on Hospital Course, Confounders, and Medications
Link: https://t.co/TS2QnRDspX
@neurocritical#NeuroCritCare
Words cannot describe how honored I am to have received FNCS designation this year from @neurocritical, humbled to reflect on where I started my journey in NCC, today, and where we are going as a community to be a positive impact on patient care
@GilbertPharmD Sign of a successful talk - engaged audience + established trust as a reliable source to answer questions they may have. For me at least, the speaker high comes from the audience engagement piece and not actually giving the presentation
@phil_bilodeau@AJWPharm@LorneSchweitzer Would love to see a bit more info than what manuscript provides. Is there opportunity to stratify by risk before substituting one risk for another (MDRO infxn) with chronic ppx? Certainly something to counsel on, monitor for, and consider empiric coverage for if infxn concern!
Congratulations to @sherifelezaby for leading this effort, was great to be a part of this collaboration to better understand variability in nimodipine administration techniques and associations with outcomes
I am thrilled to share the publication of our multicenter study in @PharmacoJournal (2021 impact factor 6.251). Included 727 patients and conducted in 21 hospitals across North America. See thread #ICU#nimodine#pharmacy#pharmacist
https://t.co/oXAGD2Dbm9
When The Electric⚡️Circuit Is Not Working, It Is Time to Check All Outlets 🔌 How Status Epilepticus 🧠 May Impact Cardiac Electric Activity🫀
Check out our editorial on the ICTAL registry📑 heart-brain crosstalk & CV effects of antiseizure meds!💊
https://t.co/7qTwG8nz8i
Tomorrow is International Day of Women and Girls in Science. We’re proud of our #WomenInScience at the forefront of helping us improve lives affected by seizure disorders. Read what Megan Barra, Associate Director, Scientific/Medical Affairs said about the importance of this day.
Leveraging EHR clinical decision support is one strategy to support patient safety and reduce drug-disease interactions in patients with rare neuromuscular disorders. More work to be done as a community. Learn from our experience @MGHNeurology@MGHNeuroICU https://t.co/SKNAIr7r0t